McKesson Corporation (0JZU.L)
USD 699.01
(1.04%)
USD 699.01
(1.04%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 4.66 Billion USD | -3.82% |
| 2022 | 5.73 Billion USD | 42.59% |
| 2021 | 3.1 Billion USD | -21.29% |
| 2020 | -3.59 Billion USD | 20.26% |
| 2019 | 2.31 Billion USD | -2.31% |
| 2018 | 4.06 Billion USD | 4.0% |
| 2017 | 3.85 Billion USD | -9.26% |
| 2016 | 4.39 Billion USD | -9.9% |
| 2015 | 4.55 Billion USD | 14.51% |
| 2014 | 4.13 Billion USD | 26.14% |
| 2013 | 3.05 Billion USD | 14.13% |
| 2012 | 2.73 Billion USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 1.32 Billion USD | -6.38% |
| 2023 Q1 | 1.19 Billion USD | -10.23% |
| 2023 Q2 | 1.05 Billion USD | -11.57% |
| 2023 FY | - USD | -14.09% |
| 2023 Q3 | 782 Million USD | -25.88% |
| 2023 Q4 | 1.53 Billion USD | 95.91% |
| 2022 Q2 | 1.35 Billion USD | 6.59% |
| 2022 Q1 | 1.27 Billion USD | 28.53% |
| 2022 Q4 | 1.32 Billion USD | -1.34% |
| 2022 FY | - USD | 42.59% |
| 2022 Q3 | 1.34 Billion USD | -0.88% |
| 2021 FY | - USD | -21.29% |
| 2021 Q1 | 1.1 Billion USD | -20.8% |
| 2021 Q2 | 940 Million USD | -15.16% |
| 2021 Q4 | 992 Million USD | 79.06% |
| 2021 Q3 | 554 Million USD | -41.06% |
| 2020 Q4 | 1.39 Billion USD | 28.7% |
| 2020 FY | - USD | 20.26% |
| 2020 Q1 | 813 Million USD | -28.81% |
| 2020 Q2 | 985 Million USD | 21.16% |
| 2020 Q3 | 1.08 Billion USD | 10.36% |
| 2019 Q3 | 726 Million USD | -17.69% |
| 2019 Q4 | 1.14 Billion USD | 57.3% |
| 2019 Q1 | 869 Million USD | -19.24% |
| 2019 Q2 | 882 Million USD | 1.5% |
| 2019 FY | - USD | -2.31% |
| 2018 FY | - USD | 4.0% |
| 2018 Q4 | 1.07 Billion USD | -0.37% |
| 2018 Q3 | 1.08 Billion USD | 3.05% |
| 2018 Q2 | 1.04 Billion USD | 15.55% |
| 2018 Q1 | 907 Million USD | -6.2% |
| 2017 Q1 | 849 Million USD | -4.28% |
| 2017 Q2 | 1.06 Billion USD | 25.68% |
| 2017 Q3 | 989 Million USD | -7.31% |
| 2017 Q4 | 967 Million USD | -2.22% |
| 2017 FY | - USD | -9.26% |
| 2016 FY | - USD | -9.9% |
| 2016 Q4 | 887 Million USD | -19.87% |
| 2016 Q3 | 1.1 Billion USD | -0.81% |
| 2016 Q2 | 1.11 Billion USD | -11.43% |
| 2016 Q1 | 1.26 Billion USD | 7.51% |
| 2015 FY | - USD | 14.51% |
| 2015 Q4 | 1.17 Billion USD | -1.84% |
| 2015 Q3 | 1.19 Billion USD | -1.24% |
| 2015 Q1 | 1.15 Billion USD | 14.3% |
| 2015 Q2 | 1.2 Billion USD | 5.04% |
| 2014 Q4 | 1 Billion USD | -6.15% |
| 2014 FY | - USD | 26.14% |
| 2014 Q1 | 1.01 Billion USD | 24.23% |
| 2014 Q2 | 1.07 Billion USD | 6.44% |
| 2014 Q3 | 1.07 Billion USD | -0.19% |
| 2013 FY | - USD | 14.13% |
| 2013 Q1 | 845 Million USD | 4.06% |
| 2013 Q3 | 717 Million USD | -20.69% |
| 2013 Q4 | 813 Million USD | 13.39% |
| 2013 Q2 | 904 Million USD | 6.98% |
| 2012 Q3 | 671 Million USD | 0.0% |
| 2012 Q4 | 812 Million USD | 21.01% |
| 2012 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Phreesia, Inc. | -102.94 Million USD | 4633.489% |
| Accuray Incorporated | 9 Million USD | -51703.752% |
| Align Technology, Inc. | 799.03 Million USD | -484.077% |
| Elevance Health Inc. | 10.49 Billion USD | 55.51% |
| AxoGen, Inc. | -13.32 Million USD | 35116.507% |
| Boston Scientific Corporation | 3.61 Billion USD | -29.172% |
| CVS Health Corporation | 18.17 Billion USD | 74.326% |
| Cardinal Health, Inc. | 1.97 Billion USD | -135.945% |
| Centene Corporation | -463 Million USD | 1107.991% |
| DaVita Inc. | 2.34 Billion USD | -98.897% |
| HCA Healthcare, Inc. | 12.72 Billion USD | 63.313% |
| Hologic, Inc. | 1.29 Billion USD | -260.052% |
| Humana Inc. | -561 Million USD | 931.907% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | -283.275% |
| Laboratory Corporation of America Holdings | 1.34 Billion USD | -245.857% |
| Masimo Corporation | 236.7 Million USD | -1871.694% |
| Patterson Companies, Inc. | 374.75 Million USD | -1145.344% |
| Quest Diagnostics Incorporated | 1.73 Billion USD | -169.457% |
| ResMed Inc. | 1.6 Billion USD | -191.627% |
| Henry Schein, Inc. | 943 Million USD | -394.91% |
| Teladoc Health, Inc. | 153.99 Million USD | -2930.579% |
| Universal Health Services, Inc. | 1.74 Billion USD | -167.692% |
| Veeva Systems Inc. | 429.33 Million USD | -987.032% |
| Baxter International Inc. | 2.77 Billion USD | -68.12% |
| Becton, Dickinson and Company | 4.27 Billion USD | -9.17% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | -94.938% |
| Danaher Corporation | 7.49 Billion USD | 37.765% |
| Stryker Corporation | 5.16 Billion USD | 9.554% |
| Medtronic plc | 9.05 Billion USD | 48.465% |